GPhA In Transition: Milanese Steps In As Hatch/Waxman Hill Debate Looms
This article was originally published in The Tan Sheet
Executive Summary
A transition in the Generic Pharmaceutical Association's leadership comes as pressure for congressional action on Hatch/Waxman reform increases
You may also be interested in...
GPhA President Jaeger Has Experience In Legal, Regulatory Technicalities
Generic Pharmaceutical Association President Kathleen Jaeger brings experience in legal and regulatory analysis to the trade association
NAPM/GPhA Merger Likely Ends Generic User Fees Push In 107th
The merger agreement between the National Association of Pharmaceutical Manufacturers and the Generic Pharmaceutical Association likely means generic drug user fees will not be a focal point of the PDUFA reauthorization process.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC